Navi Mumbai, India

Bijukumar G Pillai

This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals S.a.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bijukumar G Pillai. Retrieved from https://idiyas.com/inventor/bijukumar-g-pillai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Bijukumar G Pillai

Introduction: Bijukumar G Pillai is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work is characterized by a focus on innovative processes that enhance the efficacy of medicinal compounds.

Latest Patents: Bijukumar G Pillai holds a patent for the process of preparing N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide. This invention relates to a method of synthesizing this compound and its pharmaceutically acceptable salts, including its sodium salt. The patent also includes novel intermediate compounds that are useful in the synthesis of the aforementioned compound.

Career Highlights: Bijukumar G Pillai is associated with Glenmark Pharmaceuticals S.A., where he has been instrumental in advancing pharmaceutical research and development. His expertise in the field has led to the successful formulation of innovative drugs that address various health challenges.

Collaborations: Some of his notable coworkers include Laxmikant Atmaram Gharat and Batchu Chandrasekhar, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion: Bijukumar G Pillai's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to impact the development of effective medicinal compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…